FDA staff said a proposed sleep drug from Merck was effective, but questioned the safety of the product's higher doses. Merck is seeking FDA approval of a drug called suvorexant to treat insomnia. The product will be reviewed Wednesday by an FDA advisory committee.
Next month, iShares, the largest ETF provider by assets, will do something it hasn't done in more than a decade: close one of its 290 ETFs. Experts say that highlights the complications that arise when funds drop out.
President Obama says you have to work twice as hard if you are black. Do you agree?